Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanofi 2 ADR Representing Ord Shs SNY

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Recent & Breaking News (NDAQ:SNY)

Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session

PR Newswire November 21, 2019

Cancer Drugs Poised to Improve as New Developments Help Previous Therapies Target Better

Livemoney November 18, 2019

FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older

PR Newswire November 4, 2019

Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes

PR Newswire November 4, 2019

Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada

PR Newswire October 18, 2019

Hagens Berman: Law Firm Taking on Drug Makers in Zantac Class Action Condemns FDA's "Reckless" Cover-up of Ranitidine Carcinogen

Business Wire October 3, 2019

New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer

PR Newswire September 30, 2019

Sanofi Canada receives Gold-Level Parity Certification

Canada NewsWire September 26, 2019

Hagens Berman Files Second Class-Action Lawsuit Regarding Concealed Zantac Cancer Risk

Business Wire September 20, 2019

Hagens Berman: National Class-Action Lawsuit Accuses Sanofi of Concealing Zantac Cancer Risk

Business Wire September 13, 2019

Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose

GlobeNewswire July 23, 2019

Canadian employers underestimate the presence of chronic disease in the workforce

Canada NewsWire June 11, 2019

Sanofi oncology pipeline targeting various cancers highlighted at ASCO 2019

PR Newswire May 15, 2019

Sanofi Announces Licensing of Dupixent® ? (dupilumab) in the EU for the Treatment of Severe Asthma With Type 2 Inflammation[1]

PR Newswire May 8, 2019

FDA approves Dengvaxia® for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas

PR Newswire May 1, 2019

Sangamo Soars Amid Multiple Development Pipeline Updates

Benzinga.com  April 2, 2019

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Benzinga.com  March 29, 2019

The Genfit IPO: What You Need To Know

Benzinga.com  March 26, 2019

Apple Arcade Is The Company's Newest Subscription Gaming Service

Benzinga.com  March 25, 2019

Altimmune's Flu Shot Study: What You Need To Know

Benzinga.com  March 19, 2019